Canadian Vaccine Manufacturer Able to Deliver Doses Ahead of Schedule

From Canada Newswire English (October 9, 2008) MISSISSAUGA, ON, Oct. 9 /CNW/ - GlaxoSmithKline Inc. (GSK) today announced that it has begun shipment of FLUVIRAL(R) (Influenza Virus Vaccine) to Canadian private market customers for the 2008-2009 influenza season, having met and exceeded the contractual timelines for public market deliveries. With the majority of doses already delivered to provinces across Canada, GSK has also begun to ship vaccine to direct customers, including physicians and clinics, which will allow customers to begin immunizing patients as soon as possible. "We are pleased to be able to quickly supply influenza vaccine in Canada for the 2008-2009 season," said Dr. Tjark Reblin, Vice President Medical and Chief Medical Officer, GlaxoSmithKline Inc. "We are excited to play an integral part in helping... [read full story]